Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
Clinical trial NCT06393335 · UNKNOWN
Trial details
- NCT number
- NCT06393335
- Sponsor
- The Children's Hospital of Zhejiang University School of Medicine
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2026-03-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.